Cargando…

Therapeutic Drug Monitoring in Non-Tuberculosis Mycobacteria Infections

Nontuberculous mycobacteria can cause minimally symptomatic self-limiting infections to progressive and life-threatening disease of multiple organs. Several factors such as increased testing and prevalence have made this an emerging infectious disease. Multiple guidelines have been published to guid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alffenaar, Jan-Willem, Märtson, Anne-Grete, Heysell, Scott K., Cho, Jin-Gun, Patanwala, Asad, Burch, Gina, Kim, Hannah Y., Sturkenboom, Marieke G. G., Byrne, Anthony, Marriott, Debbie, Sandaradura, Indy, Tiberi, Simon, Sintchencko, Vitali, Srivastava, Shashikant, Peloquin, Charles A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8195771/ https://www.ncbi.nlm.nih.gov/pubmed/33751415 http://dx.doi.org/10.1007/s40262-021-01000-6

Ejemplares similares

Standard ganciclovir dosing results in slow decline of cytomegalovirus viral loads
por: Märtson, Anne-Grete, et al.
Publicado: (2021)

Therapeutic Drug Monitoring of Ganciclovir: Where Are We?
por: Märtson, Anne-Grete, et al.
Publicado: (2022)

Population Pharmacokinetics and Bayesian Dose Adjustment to Advance TDM of Anti-TB Drugs
por: Sturkenboom, Marieke G. G., et al.
Publicado: (2021)

Subtherapeutic Exposure of Ganciclovir in Children Despite Appropriate Dosing: A Short Communication
por: Marfil, Sjanene, et al.
Publicado: (2023)

Precision Therapy for Invasive Fungal Diseases
por: Märtson, Anne-Grete, et al.
Publicado: (2021)

Molecular Epidemiology of Imported Cases of Leishmaniasis in Australia from 2008 to 2014
por: Roberts, Tamalee, et al.
Publicado: (2015)

1538. Who Will Benefit From Therapeutic Drug Monitoring of Ganciclovir?
por: Martson, Anne-Grete, et al.
Publicado: (2019)

Exposure of anti-infective drugs and the dynamic changes of the gut microbiota during gastrointestinal mucositis in autologous stem cell transplant patients: a pilot study
por: Märtson, Anne-Grete, et al.
Publicado: (2023)

Saliva for Precision Dosing of Antifungal Drugs: Saliva Population PK Model for Voriconazole Based on a Systematic Review.
por: Kim, Hannah Yejin, et al.
Publicado: (2020)

2260. Clofazimine Safety and Efficacy for Treatment of Multidrug-Resistant Non-Tuberculous Mycobacteria (NTM)
por: Alameer, Reem, et al.
Publicado: (2019)

Discrepancies Between Bayesian Vancomycin Models Can Affect Clinical Decisions in the Critically Ill
por: Patanwala, Asad E., et al.
Publicado: (2022)

Ganciclovir therapeutic drug monitoring in transplant recipients
por: Märtson, Anne-Grete, et al.
Publicado: (2021)

Editorial: Pharmacology of infectious diseases: world tuberculosis day 2022
por: Srivastava, Shashikant, et al.
Publicado: (2023)

Clinical evaluation of SARS-CoV-2 point-of-care antibody tests
por: Robosa, Roselle S., et al.
Publicado: (2020)

Update on antimicrobial resistance: mechanisms, methods and practice
por: Abbott, Iain, et al.
Publicado: (2012)

Ganciclovir Therapeutic Drug Monitoring: A Case Series
por: Märtson, Anne-Grete, et al.
Publicado: (2019)

Pharmacogenomic testing: perception of clinical utility, enablers and barriers to adoption in Australian hospitals
por: Pearce, Angela, et al.
Publicado: (2022)

Mast Cells Differentiated in Synovial Fluid and Resident in Osteophytes Exalt the Inflammatory Pathology of Osteoarthritis
por: Kulkarni, Priya, et al.
Publicado: (2022)

Caspofungin Weight-Based Dosing Supported by a Population Pharmacokinetic Model in Critically Ill Patients
por: Märtson, Anne-Grete, et al.
Publicado: (2020)

Does Chemotherapy-Induced Gastrointestinal Mucositis Affect the Bioavailability and Efficacy of Anti-Infective Drugs?
por: da Silva Ferreira, Ana Rita, et al.
Publicado: (2021)

Malnutrition assessment methods in adult patients with tuberculosis: a systematic review
por: ter Beek, Lies, et al.
Publicado: (2021)

Exploring failure of antimicrobial prophylaxis and pre-emptive therapy for transplant recipients: a systematic review
por: Märtson, Anne-Grete, et al.
Publicado: (2020)

A Large Sample Retrospective Study on the Distinction of Voriconazole Concentration in Asian Patients from Different Clinical Departments
por: Zhao, Yichang, et al.
Publicado: (2021)

Integrating Pharmacokinetics and Pharmacodynamics in Operational Research to End Tuberculosis
por: Alffenaar, Jan-Willem C, et al.
Publicado: (2020)

Posaconazole therapeutic drug monitoring in clinical practice and longitudinal analysis of the effect of routine laboratory measurements on posaconazole concentrations
por: Märtson, Anne‐Grete, et al.
Publicado: (2019)

Dried Blood Spot Sampling to Assess Rifampicin Exposure and Treatment Outcomes among Native and Non-Native Tuberculosis Patients in Paraguay: An Exploratory Study
por: Ghimire, Samiksha, et al.
Publicado: (2023)

Practices of therapeutic drug monitoring in tuberculosis: an international survey
por: Margineanu, Ioana, et al.
Publicado: (2022)

1139. Novel Formulation SUBA-Itraconazole Prophylaxis in Patients With Hematological Malignancy or Undergoing Allogeneic Stem Cell Transplantation: Follow-up Survival Data
por: Lindsay, Julian, et al.
Publicado: (2018)

Therapeutic Drug Monitoring of Posaconazole: an Update
por: Dekkers, Bart G. J., et al.
Publicado: (2016)

Mycobacterium tuberculosis sterilizing activity of faropenem, pyrazinamide and linezolid combination and failure to shorten the therapy duration
por: Gumbo, Tawanda, et al.
Publicado: (2021)

Mycobacteria in keloid
por: Singh, Ashish, et al.
Publicado: (2011)

C/MIC > 4: A Potential Instrument to Predict the Efficacy of Meropenem
por: Zhao, Yichang, et al.
Publicado: (2022)

Prospective evaluation of improving fluoroquinolone exposure using centralised therapeutic drug monitoring (TDM) in patients with tuberculosis (PERFECT): a study protocol of a prospective multicentre cohort study
por: van den Elsen, Simone HJ, et al.
Publicado: (2020)

Pharmacokinetics of rifampicin in adult TB patients and healthy volunteers: a systematic review and meta-analysis
por: Stott, K E, et al.
Publicado: (2018)

An update on drug-drug interactions for care of the acutely ill in the era of COVID-19
por: Patanwala, Asad E, et al.
Publicado: (2023)

Outcomes and Use of Therapeutic Drug Monitoring in Multidrug-Resistant Tuberculosis Patients Treated in Virginia, 2009-2014
por: Heysell, Scott K., et al.
Publicado: (2015)

Key Transitions in the Evolution of Rapid and Slow Growing Mycobacteria Identified by Comparative Genomics
por: Bachmann, Nathan L., et al.
Publicado: (2020)

Nontuberculous Mycobacteria from Household Plumbing of Patients with Nontuberculous Mycobacteria Disease
por: Falkinham, Joseph O.
Publicado: (2011)

Educational Case: Identification of Pulmonary Mycobacteria
por: Tremblay, Elizabeth E., et al.
Publicado: (2020)

Number Needed to Scan: Evidence-Based Point-of-Care Ultrasound (POCUS)
por: Amini, Richard, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tu8qje6dvqqipflg6s65vnul7e